BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,454,000 | -0.4% | 42,694 | -4.0% | 0.42% | +5.5% |
| Q2 2022 | $6,480,000 | -35.4% | 44,475 | -47.4% | 0.40% | -24.6% |
| Q1 2022 | $10,032,000 | -16.7% | 84,609 | -3.1% | 0.53% | -9.8% |
| Q4 2021 | $12,037,000 | -24.2% | 87,347 | -23.6% | 0.59% | -29.1% |
| Q3 2021 | $15,875,000 | +44.3% | 114,286 | +0.8% | 0.83% | +42.1% |
| Q2 2021 | $11,005,000 | +65.1% | 113,362 | +16.3% | 0.59% | +46.8% |
| Q1 2021 | $6,664,000 | – | 97,498 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |